Company Profile (AI Text)
Name: DermaSensor Inc.
Canonical URL: https://wefunder.com/dermasensor
Updated at: 2026-07-17T00:08:45Z

Tagline: Award-winning FDA-cleared AI bringing skin cancer detection to non-specialist clinicians

Key claims:
- Total raised on Wefunder: 699999 | citation: https://wefunder.com/dermasensor#claim-total-raised
- Total investors: 3 | citation: https://wefunder.com/dermasensor#claim-total-investors

Verified facts:
- Total raised on Wefunder: 699999 | observed_at: 2026-07-17T00:08:45Z | expires_at: 2026-07-18T00:08:45Z
- Total investors: 3 | observed_at: 2026-07-17T00:08:45Z | expires_at: 2026-07-18T00:08:45Z

Computed metrics:
- total_amount_raised: 699999
- total_investors: 3
- team_size: 7
- featured_investor_count: 4
- faq_count: 0
- recent_post_count: 0

Quick facts:
- First & only automated skin cancer detection tool cleared by the FDA for Primary Care Physicians | citation: https://wefunder.com/dermasensor#claim-fact-1
- $1M contracted ARR at year-end 2025 driven by 3X growth in paid devices YoY | citation: https://wefunder.com/dermasensor#claim-fact-2
- 40K lesions scanned, 9 published clinical studies; device cuts physicians missed cancers by 50-68% | citation: https://wefunder.com/dermasensor#claim-fact-3
- $20M raised including Pier 70 Ventures, Kern Venture Group & GenHenn Venture | citation: https://wefunder.com/dermasensor#claim-fact-4
- Exited unicorn co-founder ($1.65B to Stryker); leadership from Genentech, Optum, & Abbott | citation: https://wefunder.com/dermasensor#claim-fact-5
- 10 US health systems & 100s of practices under contract; Class 2b CE Mark in Europe; 5 patents | citation: https://wefunder.com/dermasensor#claim-fact-6
- TIME Best Invention, Inc. Best in Innovation, Edison & SXSW winner; Forbes & CBS features | citation: https://wefunder.com/dermasensor#claim-fact-7
- $8B+ US & European market across 1.5M+ frontline clinicians evaluating suspicious lesions | citation: https://wefunder.com/dermasensor#claim-fact-8